Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure.

Abstract:

:In a phase I/II study, 19 patients with advanced tumors but normal hematopoiesis and nine patients with bone marrow failure and prolonged severe cytopenias were treated with recombinant human interleukin-3 (rhIL-3) to assess the toxicity and biological effects of this multipotential hematopoietic growth factor. Doses ranging from 30 micrograms/m2 to 500 micrograms/m2 were administered as subcutaneous bolus injection daily for 15 days. A dose-dependent increase in platelet counts ranging from 1.3-fold at 60 micrograms/m2 to 1.9-fold at 250 micrograms/m2 was induced by rhIL-3 in 15 of 18 evaluable patients with normal hematopoiesis. An increase in reticulocyte counts was observed in 14 patients. The blood leukocyte counts dose dependently increased 1.4- to 3.0-fold. In patients with bone marrow failure, platelet counts increased by a mean of sixfold (range, 1.3-fold to 14.3-fold) in five of eight evaluable patients. Reticulocyte counts increased 4.4-fold in six patients, and neutrophil counts increased by a mean of 3.1-fold in all eight patients. Platelet transfusions could be discontinued after treatment with rhIL-3 in two of three transfusion-dependent patients. Only mild side effects, mainly fever, headache, and flushing, were observed. These results indicate that rhIL-3 functions as a multilineage hematopoietin in vivo in patients with normal bone marrow function and in patients with secondary bone marrow failure.

journal_name

Blood

journal_title

Blood

authors

Ganser A,Lindemann A,Seipelt G,Ottmann OG,Herrmann F,Eder M,Frisch J,Schulz G,Mertelsmann R,Hoelzer D

subject

Has Abstract

pub_date

1990-08-15 00:00:00

pages

666-76

issue

4

eissn

0006-4971

issn

1528-0020

journal_volume

76

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Relevance of marrow fibrosis in bone marrow transplantation: a retrospective analysis of engraftment.

    abstract::A retrospective study compared posttransplant engraftment parameters in 203 patients with myelofibrosis (MF) with those in a population of 203 matched controls without MF. There were no significant differences between these groups in the proportions of patients who died without achieving engraftment and in the disease...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Soll E,Massumoto C,Clift RA,Buckner CD,Appelbaum FR,Storb R,Sale G,Hackman R,Martin P

    更新日期:1995-12-15 00:00:00

  • Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation.

    abstract::Activation of endothelial cells, important in processes such as angiogenesis, is regulated by cell surface receptors, including those in the tyrosine kinase (RTK) family. Receptor activity, in turn, can be modulated by phosphorylation, turnover, or proteolytic release of a soluble extracellular domain. Previously, we ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yabkowitz R,Meyer S,Black T,Elliott G,Merewether LA,Yamane HK

    更新日期:1999-03-15 00:00:00

  • Human natural killer cell expansion is regulated by thrombospondin-mediated activation of transforming growth factor-beta 1 and independent accessory cell-derived contact and soluble factors.

    abstract::Natural killer cells (NK) were studied to determine factors important in their expansion. Flourescence-activated cell sorter (FACS) purified CD56+/CD3- NK cells cultured alone for 18 days in rIL-2 containing medium (1,000 U/mL) showed enhanced cytotoxicity but only minimal expansion. NK expansion was increased (12.5 +...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pierson BA,Gupta K,Hu WS,Miller JS

    更新日期:1996-01-01 00:00:00

  • MicroRNA-139-5p regulates proliferation of hematopoietic progenitors and is repressed during BCR-ABL-mediated leukemogenesis.

    abstract::MicroRNAs (miRNAs) have emerged as important regulators of the immune system. However, despite this prominence, our understanding of the function of miRNAs in the early hematopoietic stages is incomplete. In this study, we found that miR-139-5p negatively regulated the proliferation of hematopoietic stem cells and pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-02-702464

    authors: Choi J,Kim YK,Park K,Nah J,Yoon SS,Kim DW,Kim VN,Seong RH

    更新日期:2016-10-27 00:00:00

  • Establishment of a karyotypically normal cytotoxic leukemic T-cell line from a T-ALL sample engrafted in SCID mice.

    abstract::Bone marrow (BM) cells from a child with an immature (CD3-) acute T lymphoblastic leukemia (T-ALL) bearing no chromosomal abnormalities failed to grow in long-term culture in the presence or absence of recombinant human (rh) growth factors but could be engrafted in severe combined immunodeficient (SCID) mice and induc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cesano A,O'Connor R,Nowell PC,Lange B,Clark SC,Santoli D

    更新日期:1993-05-15 00:00:00

  • How I treat hypereosinophilic syndromes.

    abstract::Hypereosinophilic syndromes (HESs) are a heterogeneous group of uncommon disorders characterized by marked peripheral eosinophilia and end organ manifestations attributable to the eosinophilia or unexplained in the clinical setting. Whereas corticosteroids remain the mainstay of treatment for most patients, recent dia...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2009-07-143552

    authors: Klion AD

    更新日期:2009-10-29 00:00:00

  • AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML.

    abstract::The nonobese diabetic/severe combined immunodeficient (NOD/SCID) assay is the current model for assessment of human normal and leukemic stem cells. We explored why 51% of 59 acute myeloid leukemia (AML) patients were unable to initiate leukemia in NOD/SCID mice. Increasing the cell dose, using more permissive recipien...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-06-2325

    authors: Pearce DJ,Taussig D,Zibara K,Smith LL,Ridler CM,Preudhomme C,Young BD,Rohatiner AZ,Lister TA,Bonnet D

    更新日期:2006-02-01 00:00:00

  • Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors.

    abstract::We describe the cloning and characterization of Siglec-H, a novel murine CD33-related siglec-like molecule with 2 immunoglobulin domains. Unlike other CD33-related siglecs, Siglec-H lacks tyrosine-based signaling motifs in its cytoplasmic tail. Although Siglec-H has the typical structural features required for sialic ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-09-3842

    authors: Zhang J,Raper A,Sugita N,Hingorani R,Salio M,Palmowski MJ,Cerundolo V,Crocker PR

    更新日期:2006-05-01 00:00:00

  • The phagocytes: neutrophils and monocytes.

    abstract::The production and deployment of phagocytes are central functions of the hematopoietic system. In the 1950s, radioisotopic studies demonstrated the high production rate and short lifespan of neutrophils and allowed researchers to follow the monocytes as they moved from the marrow through the blood to become tissue mac...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2007-12-077917

    authors: Dale DC,Boxer L,Liles WC

    更新日期:2008-08-15 00:00:00

  • Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions.

    abstract::Endothelial cell-mediated coagulation and leukocyte adhesion are processes that might be connected by the generation of thrombin. To examine the interaction of procoagulant and proadhesive activity, cultures of endothelial cells were stimulated with tumor necrosis factor-alpha, which resulted in the surface expression...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kirchhofer D,Sakariassen KS,Clozel M,Tschopp TB,Hadváry P,Nemerson Y,Baumgartner HR

    更新日期:1993-04-15 00:00:00

  • Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcgammaRIIa.

    abstract::Collagen binding to glycoprotein VI (GPVI) induces signals critical for platelet activation in thrombosis. Both ligand-induced GPVI signaling through its coassociated Fc-receptor gamma-chain (FcRgamma) immunoreceptor tyrosine-activation motif (ITAM) and the calmodulin inhibitor, W7, dissociate calmodulin from GPVI and...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-04-086983

    authors: Gardiner EE,Karunakaran D,Arthur JF,Mu FT,Powell MS,Baker RI,Hogarth PM,Kahn ML,Andrews RK,Berndt MC

    更新日期:2008-01-01 00:00:00

  • Transcriptional and posttranscriptional regulation of the interleukin-4 and interleukin-3 genes in human T cells.

    abstract::Human T cells were studied with regard to the regulation of interleukin-4 (IL-4) and IL-3 gene expression. IL-4 and IL-3 mRNA were undetectable in unstimulated T cells. On activation with the lectin concanavalin A (Con A), both IL-4 and IL-3 mRNA were expressed. Accumulation of IL-4 mRNA peaked after 6 to 12 hours, wh...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dokter WH,Esselink MT,Sierdsema SJ,Halie MR,Vellenga E

    更新日期:1993-01-01 00:00:00

  • Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?

    abstract::Despite many studies on the pathophysiology of antiphospholipid antibodies (aPL), the mechanism by which aPL causes thrombosis has not been established. We have tried to elucidate the paradox between the prolongation of the clotting time of phospholipid-dependent coagulation tests in vitro and the occurrence of thromb...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Oosting JD,Derksen RH,Bobbink IW,Hackeng TM,Bouma BN,de Groot PG

    更新日期:1993-05-15 00:00:00

  • Extraembryonic expression of EPCR is essential for embryonic viability.

    abstract::The endothelial cell protein C receptor (EPCR) augments protein C activation by the thrombin-thrombomodulin complex. Deletion of the EPCR gene (Procr) in mice leads to embryonic lethality before embryonic day 10 (E10.0). EPCR is detected in the giant trophoblast cells at the feto-maternal boundary from E7.5 and weakly...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-01-0406

    authors: Li W,Zheng X,Gu JM,Ferrell GL,Brady M,Esmon NL,Esmon CT

    更新日期:2005-10-15 00:00:00

  • SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells.

    abstract::Chemokine stromal derived factor 1 (SDF-1) is involved in trafficking of hematopoietic stem cells (HSCs) from the bone marrow (BM) to peripheral blood (PB) and has been found to enhance postischemia angiogenesis. This study was aimed at investigating whether SDF-1 plays a role in differentiation of BM-derived c-kit(+)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-12-4423

    authors: De Falco E,Porcelli D,Torella AR,Straino S,Iachininoto MG,Orlandi A,Truffa S,Biglioli P,Napolitano M,Capogrossi MC,Pesce M

    更新日期:2004-12-01 00:00:00

  • Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRgamma deficiency.

    abstract::Fibrillar collagens are among the most potent activators of platelets and play an important role in the initiation of thrombosis. The glycoprotein VI (GPVI)/FcRgamma-chain complex is a central collagen receptor and inhibitors of GPVI produce a major defect in arterial thrombogenesis. In this study we have examined art...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4244

    authors: Mangin P,Yap CL,Nonne C,Sturgeon SA,Goncalves I,Yuan Y,Schoenwaelder SM,Wright CE,Lanza F,Jackson SP

    更新日期:2006-06-01 00:00:00

  • The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

    abstract::Chronic myeloid leukemia is effectively treated with imatinib, but reactivation of BCR-ABL frequently occurs through acquisition of kinase domain mutations. The additional approved ABL tyrosine kinase inhibitors (TKIs) nilotinib and dasatinib, along with investigational TKIs such as ponatinib (AP24534) and DCC-2036, s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-05-349191

    authors: O'Hare T,Zabriskie MS,Eide CA,Agarwal A,Adrian LT,You H,Corbin AS,Yang F,Press RD,Rivera VM,Toplin J,Wong S,Deininger MW,Druker BJ

    更新日期:2011-11-10 00:00:00

  • Drug-induced thrombocytopenia: development of a novel NOD/SCID mouse model to evaluate clearance of circulating platelets by drug-dependent antibodies and the efficacy of IVIG.

    abstract::Drug-induced immune thrombocytopenia (DITP) is an adverse drug effect mediated by drug-dependent antibodies. Intravenous immunoglobulin (IVIG) is frequently used to treat DITP and primary immune thrombocytopenia (ITP). Despite IVIG's proven beneficial effects in ITP, its efficacy in DITP is unclear. We have establishe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-02-268326

    authors: Liang SX,Pinkevych M,Khachigian LM,Parish CR,Davenport MP,Chong BH

    更新日期:2010-09-16 00:00:00

  • Brain endothelium lack one of two pathways of P-selectin-mediated neutrophil adhesion.

    abstract::P-selectin, an endothelial leukocyte adhesion receptor, is rapidly translocated to the cell surface upon release from storage granules called Weibel-Palade bodies and is also transcriptionally upregulated upon cytokine stimulation of endothelial cells (ECs). These two pathways of surface expression are coincident with...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Barkalow FJ,Goodman MJ,Gerritsen ME,Mayadas TN

    更新日期:1996-12-15 00:00:00

  • Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishin

    abstract::The purpose of this study was to compare transplantation outcomes in patients with hematologic malignancies who received marrow grafts from either phenotypically matched unrelated, one-antigen-mismatched unrelated, or highly human leukocyte antigen (HLA)-disparate family donors. Between 1993 and 2000, 139 patients und...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.3.806

    authors: Drobyski WR,Klein J,Flomenberg N,Pietryga D,Vesole DH,Margolis DA,Keever-Taylor CA

    更新日期:2002-02-01 00:00:00

  • Overlapping and divergent signaling pathways of N-cadherin and VE-cadherin in endothelial cells.

    abstract::Endothelial cells (ECs) express 2 members of the cadherin family, VE and N-cadherin. Although VE-cadherin induces EC homotypic adhesion, N-cadherin function in ECs remains largely unknown. EC-specific inactivation of either VE or N-cadherin leads to early fetal lethality suggesting that these cadherins play a nonredun...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-09-381012

    authors: Giampietro C,Taddei A,Corada M,Sarra-Ferraris GM,Alcalay M,Cavallaro U,Orsenigo F,Lampugnani MG,Dejana E

    更新日期:2012-03-01 00:00:00

  • Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions.

    abstract::The effectiveness of arabinosylcytosine (ara-C) for the treatment of acute myelogenous leukemia (AML) depends on the formation of its active metabolite, the triphosphate of ara-C (ara-CTP). Using biochemical modulation strategies to increase the accumulation of ara-CTP in leukemia blasts, a clinical protocol was desig...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Gandhi V,Estey E,Keating MJ,Chucrallah A,Plunkett W

    更新日期:1996-01-01 00:00:00

  • p55 and p75 tumor necrosis factor receptors in patients with chronic lymphocytic leukemia.

    abstract::We studied the expression of the two tumor necrosis factor (TNF) receptors, p55 and p75, on B cells from patients with chronic lymphocytic leukemia (CLL), and the presence of soluble TNF receptors in serum. Expression of membrane-associated receptors was quantified by double labeling of peripheral blood mononuclear ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Waage A,Liabakk N,Lien E,Lamvik J,Espevik T

    更新日期:1992-11-15 00:00:00

  • Increased death receptor resistance and FLIPshort expression in polycythemia vera erythroid precursor cells.

    abstract::Polycythemia vera (PV) is a clonal myeloproliferative disorder characterized by excessive erythrocyte production. Most patients with PV harbor an activating JAK2 mutation, but the molecular links between this mutation and erythrocyte overproduction are unknown. The interaction between death receptors and their ligands...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-07-3037

    authors: Zeuner A,Pedini F,Signore M,Ruscio G,Messina C,Tafuri A,Girelli G,Peschle C,De Maria R

    更新日期:2006-05-01 00:00:00

  • Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety.

    abstract::The molecular backgrounds of variants encountered in Afro-Caribbean black individuals and associated with the production of clinically significant antibodies against high-incidence antigens (anti-RH18, anti-RH34) and against Rhe epitopes were determined. We showed that RH:-18 phenotypes are produced by 3 distinct RHCE...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-01-0229

    authors: Noizat-Pirenne F,Lee K,Pennec PY,Simon P,Kazup P,Bachir D,Rouzaud AM,Roussel M,Juszczak G,Ménanteau C,Rouger P,Kotb R,Cartron JP,Ansart-Pirenne H

    更新日期:2002-12-01 00:00:00

  • Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2.

    abstract::The stage of progenitor maturation and factors that determine the fate and clonal acquisition of human natural killer (NK) cell receptors during development are unknown. To study human NK cell receptor ontogeny, umbilical cord blood CD34(+)/Lin(-)/CD38(-) cells were cultured with a murine fetal liver line (AFT024) and...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.3.705

    authors: Miller JS,McCullar V

    更新日期:2001-08-01 00:00:00

  • miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response.

    abstract::FLT3-ITD+ acute myeloid leukemia (AML) accounts for ∼25% of all AML cases and is a subtype that carries a poor prognosis. microRNA-155 (miR-155) is specifically overexpressed in FLT3-ITD+ AML compared with FLT3 wild-type (FLT3-WT) AML and is critical for the growth of FLT3-ITD+ AML cells in vitro. However, miR-155's r...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-09-740209

    authors: Wallace JA,Kagele DA,Eiring AM,Kim CN,Hu R,Runtsch MC,Alexander M,Huffaker TB,Lee SH,Patel AB,Mosbruger TL,Voth WP,Rao DS,Miles RR,Round JL,Deininger MW,O'Connell RM

    更新日期:2017-06-08 00:00:00

  • Mapping of distinct von Willebrand factor domains interacting with platelet GPIb and GPIIb/IIIa and with collagen using monoclonal antibodies.

    abstract::We have used monoclonal antibodies (M Abs) and proteolytic fragmentation to localize structurally the functional sites of human von Willebrand factor (vWF) responsible for interaction with membrane glycoproteins GPIb, GPIIb/IIIa, and with collagen. SpII (215 kd) and SpIII (320 kd), the S aureus V-8 protease homodimeri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Girma JP,Kalafatis M,Piétu G,Lavergne JM,Chopek MW,Edgington TS,Meyer D

    更新日期:1986-05-01 00:00:00

  • Allogeneic peripheral blood progenitor cell transplantation in a murine model: evidence for an improved graft-versus-leukemia effect.

    abstract::Peripheral blood progenitor cells (PBPCs) are increasingly being used to replace bone marrow cells (BMCs) as a source of hematopoietic stem cells also in the field of allogeneic transplantation. Whereas it is well known that PBPC grafts and BM differ significantly in progenitor cell content and lymphocyte dose, the cl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Glass B,Uharek L,Zeis M,Dreger P,Löffler H,Steinmann J,Schmitz N

    更新日期:1997-08-15 00:00:00

  • Juvenile chronic myelogenous leukemia: characterization of the disease using cell cultures.

    abstract::To characterize juvenile chronic myelogenous leukemia (JCML), the proliferative properties of bone marrow (BM) and peripheral blood (PB) cells from nine patients were studied using assays for CFU-C and CFU-GEMM and liquid cultures. All specimens showed two reproducible abnormalities: impaired growth of normal hematopo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Estrov Z,Grunberger T,Chan HS,Freedman MH

    更新日期:1986-05-01 00:00:00